Related Experiment Video

Updated: Aug 13, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

New therapies for muscular dystrophy: cautious optimism

Giulio Cossu1, Maurilio Sampaolesi

  • 1Stem Cell Research Institute, Dibit, H. San Raffaele, 58 Via Olgettina, 20132 Milan, Italy. cossu.giulio@hsr.it

Trends in Molecular Medicine
|October 7, 2004
PubMed

Insights

Developing effective muscular dystrophy therapies remains challenging. While gene and stem cell therapies show promise, corticosteroids are the only current treatment, and combination strategies may offer future success.

Area of Science:

  • Neurology
  • Regenerative Medicine
  • Genetics

Background:

  • Muscular dystrophy research has advanced significantly over 40 years.
  • Key discoveries include satellite cells, gene mutations, gene transfer technologies, and stem cells.
  • Corticosteroids are the sole effective treatment currently available.

Purpose of the Study:

  • To review recent advances in muscular dystrophy therapeutic strategies.
  • To explore the potential of novel approaches beyond current treatments.
  • To highlight the promise of combination therapies.

Main Methods:

  • Review of scientific literature on muscular dystrophy therapies.
  • Analysis of recent progress in gene therapy and cell therapy.
  • Evaluation of emerging stem cell types for therapeutic applications.

Main Results:

  • Identification of specific gene mutations and satellite cells linked to dystrophies.
  • Development of gene transfer and modification technologies.
  • Emergence of stem cell therapies and diverse pharmacological options.
  • Potential for exon-skipping and adeno-associated virus gene therapies.

Conclusions:

  • Despite advances, effective muscular dystrophy treatments remain limited.
  • Gene therapy, cell therapy with novel stem cells, and pharmacological treatments offer new avenues.
  • Combining therapeutic strategies may significantly improve treatment efficacy for muscular dystrophy.

More Related Videos

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...